Results 61 to 70 of about 4,064 (194)

Comparison of PPD and IGST Sensitivity in Latent Tuberculosis Assessment (Cross-sectional Study)

Sakarya Tıp Dergisi
Objective: Purified Protein Derivative (PPD) and Interferon Gamma Release Assay (IGRA) were performed on patients with ankylosing spondylitis and rheumatoid arthritis who were planned to initiate immunosuppressive treatment.
Nurhan Sarıoğlu, Nilay Şahin, Mustafa Çolak, Kazım Batıhan Büyükzengin, Fuat Erel, Hikmet Çoban   +5 more
doaj   +1 more source

The “Reducing Inflammation for Greater Health Trial (RIGHT)” Study—Concept, Rationale, and Design

Journal of the American Geriatrics Society, Volume 74, Issue 3, Page 636-647, March 2026.
ABSTRACT The Reducing Inflammation for Greater Health Trial's (RIGHT) study is a single‐center, randomized, double‐blind, placebo‐controlled trial designed to test whether clazkizumab, an interleukin‐6 (IL‐6) inhibitor, can improve or slow decline in physical, cognitive, and vascular function in older adults, when compared to a placebo.
Sebastian E. Sattui, Marnie Bertolet, Daniel E. Forman, Michelle E. Danielson, Shanshan Yao, Oscar L. Lopez, Nancy W. Glynn, Neelesh K. Nadkarni, Akira Sekikawa, Tullia C. Bruno, Toren Finkel, Anne B. Newman   +11 more
wiley   +1 more source

An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population [PDF]

, 2014
Introduction Quatre génotypes pathogènes de l'hépatite E (HEV) sont actuellement connus. Ils présentent des caractéristiques épidémiologiques différentes.
Schnegg, A.
core   +2 more sources

T-Cell Xtend -reagenssin testaus pitkittyneessä T-SPOT.TB-näytekuljetuksessa [PDF]

, 2010
Latentin tuberkuloosin tutkimiseen käytettävää diagnostista in vitro ELISPOT-testiä varten otetun kokoverinäytteen lyhyt säilyvyysaika on ollut esteenä määrityksen laajemmalle käytölle, sillä näytteen käsittely tulee aloittaa neljän tunnin sisällä ...
Kookmaa, Kristel
core  

Comparison of Rifampin and Isoniazid for Latent Tuberculosis Infection in Kidney Transplant Candidates: Focus on Tolerability and Treatment Completion

Transplant Infectious Disease, Volume 28, Issue 2, March/April 2026.
This study comparing 4‐month rifampin with 9‐month isoniazid for latent tuberculosis in kidney transplant candidates showed higher treatment completion rates and no transaminase elevations in the rifampin group. However, some patients experienced an increase in blood pressure while taking antihypertensive medications known to interact with rifampin ...
Jacques Simkins, Julia Bini Viotti, Yoichiro Natori, Shweta Anjan, Adela Mattiazzi, Mariella Ortigosa‐Goggins, Giselle Guerra, David Roth, Warren Kupin, Javier A. Pagan, Franco Cabeza, Gaetano Ciancio, Mahmoud Morsi, Michele I. Morris   +13 more
wiley   +1 more source

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa [PDF]

, 2015
BACKGROUND: In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)-associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess the benefits of early antiretroviral therapy (ART), 6-month isoniazid ...
Ackoundzé, S, Ahiboh, H, Aka, K, Amon, S, Anglaret, X, Ani, A, Anzian, A, Aoussi, E, Assi, R, Attia, A, Ba-Gomis, O, Babatounde, N, Babatunde, C, Badje, A, Bakayoko, A, Bamba, D, Bissagnene, E, Bleoué, G, Bouhoussou, F, Chaix, ML, Chenal, H, Chêne, G, Daligou, M, Danel, C, Dembélé, F, Deschamps, N, Dohoun, L, Domoua, SK, Dosso, M, Eholié, SP, Emieme, A, Ettiegne-Traore, V, Gabillard, D, Girard, PM, Gnokoro, J, Gouesse, P, Guéhi, C, Hawerlander, D, Horo, A, Inwoley, A, Journot, V, Kabran, M, Kadio, A, Kamagate, S, Kanga, C, Karcher, S, Koman, M, Konan, R, Konate, S, Koné, F, Koua, A, Kouadio, AC, Kouame, A, Kouame, AB, Kouame, GM, Kouamé, A, Kouamé, E, Koule, S, Le Carrou, J, Mahassadi, A, Makaila, O, Massumbuko, JM, Mbakop, N, Menan, H, Messou, E, Minga, A, Mobio, M, Moh, R, Moh-Semdé, C, N'Dri-Yoman, T, Nchot, C, Ndri, Y, Ntakpé, JB, Nzunetu, G, Ouassa, T, Ouattara, E, Oussou, A, Oyebi, M, Perronne, C, Rabe, C, Rouzioux, C, Salamon, R, Sassan-Morokro, M, Sena, G, Sidibé, B, Sow, PS, Séri, J, Tchoutedjem, M, TEMPRANO ANRS 12136 Study Group, Toni, TD, Yao, A, Yededji, SY   +91 more
core   +1 more source

Research priorities for advanced HIV disease in Latin America and the Caribbean region: a modified Delphi study

Journal of the International AIDS Society, Volume 29, Issue 1, January 2026.
Abstract Introduction Advanced HIV disease (AHD) remains a leading cause of mortality in Latin America and the Caribbean (LAC), driven by late diagnosis, treatment gaps and structural barriers, particularly among key populations and children. Persistent disparities in healthcare access, stigma, and limited health system capacity highlight the need for ...
Evelina Chapman, Omar Sued, Jorge O. Maia Barreto, Claudia P. Cortes, Brenda Crabtree Ramírez, José E. Vidal, Antonio Camiro‐Zúñiga, Freddy Perez   +7 more
wiley   +1 more source

Accuracy of anti-mycobacterial protein 51 antibodies as a biomarker for latent TB infection in asymptomatic HIV positive individuals: a cross-sectional diagnostic study

BMC Research Notes
Objective To evaluate the diagnostic accuracy of anti-Mycobacterial Protein 51 (MPT51) antibodies in latent Tuberculosis (TB) detection among asymptomatic Human Immune Virus (HIV) positive individuals using Interferon Gamma Release Assay (IGRA ...
Josephine Victo Namugga, Carol Musubika, Stuart Niwagaba, Jonathan Mayito, Obondo James Sande   +4 more
doaj   +1 more source

Comparing QuantiFERON-TB Gold Plus with Other Tests To Diagnose Mycobacterium tuberculosis Infection [PDF]

Journal of Clinical Microbiology, 2019
The fourth-generation QuantiFERON test for tuberculosis infection, QuantiFERON-TB Gold Plus (QFT-Plus) has replaced the earlier version, QuantiFERON-TB Gold In-Tube (QFT-GIT). A clinical need exists for information about agreement between QFT-Plus and other tests.
Thara K, Venkatappa, Rose, Punnoose, Dolly J, Katz, Michael P, Higgins, Niaz, Banaei, Edward A, Graviss, Robert W, Belknap, Christine S, Ho   +7 more
openaire   +2 more sources

Cutaneous Tuberculosis Presenting as a Chronic Dermatologic Disorder

Case Reports in Dermatological Medicine, Volume 2026, Issue 1, 2026.
Cutaneous tuberculosis (CTB) is a rare manifestation of extrapulmonary tuberculosis that is frequently misdiagnosed due to its diverse clinical presentation and resemblance to other dermatological conditions. Tuberculosis verrucosa cutis (TBVC), one clinical manifestation of CTB, poses a particular diagnostic challenge, as lesions are often ...
Olivia Spina, Henry Fraimow, Justin Green, Ioannis D. Bassukas   +3 more
wiley   +1 more source